XML 39 R28.htm IDEA: XBRL DOCUMENT v3.23.3
Acquisitions and Divestitures (Tables)
9 Months Ended
Sep. 30, 2023
Business Combinations [Abstract]  
Business Combination, Separately Recognized Transactions The acquisition-date fair value of the consideration totaled $6,900 million, which consisted of the following:
(in millions)Fair Value of Purchase Consideration
Xylem Common Stock issued to Evoqua stockholders (58,779,096 shares)$6,121 
Estimated replacement equity awards 160 
Payment of certain Evoqua indebtedness 619 
Total $6,900 
Purchase Price Allocation The following table summarizes the preliminary acquisition date fair value of net tangible and intangible assets acquired, net of liabilities assumed from Evoqua:
(in millions)Fair Value
  Cash and cash equivalents$143 
  Receivables(a)
432 
  Inventories266 
  Prepaid and other current assets74 
  Assets held for sale
  Property, plant and equipment, net511 
  Goodwill4,442 
  Other intangible assets, net2,245 
  Other non-current assets192 
  Non-current assets held for sale85 
  Accounts payable(210)
  Accrued and other current liabilities(347)
 Short-term borrowings and current maturities of long-term debt(166)
  Liabilities held for sale(1)
  Long-term debt(111)
  Other non-current accrued liabilities(124)
  Deferred income tax liabilities(536)
  Non-current liabilities held for sale(3)
Total$6,900 
(a) Including $322 million of receivables and $110 million of contract assets.
Summary of Intangible Assets Acquired
The following table summarizes key information underlying identifiable intangible assets related to the Evoqua acquisition:

(in millions)Useful Life (in years)
Fair Value
(in millions)
Trademarks6$60 
Proprietary technology and patents
4 - 9
128 
Customer and distributor relationships
7 - 17
1,875 
Backlog
1 - 8
90 
Permits865 
Software
1 - 13
27 
Total$2,245 
Pro Forma Information
The amounts of revenue and net loss from continuing operations before income taxes of Evoqua since the acquisition date included in the Consolidated Income Statement are as follows:

(in millions)Three months ended September 30, 2023Nine months ended September 30, 2023
Revenue$540 $718 
Loss before taxes$14 $63 
The following table summarizes, on an unaudited pro forma basis, the condensed combined results of operations of the Company for the three and nine months ended September 30, 2023 and 2022, assuming the acquisition had occurred on January 1, 2022.

(Unaudited)
Three Months Ended
September 30,
(Unaudited)
Nine Months Ended
September 30,
(in millions)2023202220232022
Revenue$2,076 $1,885 $6,025 $5,387 
Net income $180 $28 $358 $102